1. Home
  2. SPSC vs GLPG Comparison

SPSC vs GLPG Comparison

Compare SPSC & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPS Commerce Inc.

SPSC

SPS Commerce Inc.

HOLD

Current Price

$53.58

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$27.75

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPSC
GLPG
Founded
1987
1999
Country
United States
Belgium
Employees
N/A
452
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
SPSC
GLPG
Price
$53.58
$27.75
Analyst Decision
Hold
Buy
Analyst Count
10
2
Target Price
$96.80
$36.50
AVG Volume (30 Days)
443.6K
139.8K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
20.59
N/A
EPS
0.53
N/A
Revenue
$220,566,000.00
N/A
Revenue This Year
$8.85
N/A
Revenue Next Year
$7.37
N/A
P/E Ratio
$98.96
N/A
Revenue Growth
14.11
N/A
52 Week Low
$49.04
$26.62
52 Week High
$147.61
$37.78

Technical Indicators

Market Signals
Indicator
SPSC
GLPG
Relative Strength Index (RSI) 47.30 36.53
Support Level $51.52 N/A
Resistance Level $59.73 $34.04
Average True Range (ATR) 2.57 0.56
MACD -0.12 0.08
Stochastic Oscillator 43.84 25.33

Price Performance

Historical Comparison
SPSC
GLPG

About SPSC SPS Commerce Inc.

SPS Commerce Inc is a provider of cloud-based supply chain management services for retailers, grocers, distributors, suppliers, and logistics firms to increase supply chain performance, optimize inventory levels and sell-through, reduce operational costs, improve order visibility, and satisfy consumer demands for a seamless omnichannel experience. Its solutions are delivered through the SPS Commerce platform and provide integrations and retail performance analytics to its customers. The company has one operating segment Supply Chain Management Solutions, that derives revenues from customers by providing access to cloud-based supply chain management services, primarily under subscription-based service arrangements.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, and it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: